The combination of FASN inhibitors and cisplatin also decreased fatty acid metabolism, glutamine metabolism, nucleotide and glutathione biosynthesis, and fatty acid β-oxidation in tumor cells, resulting in cell cycle arrest and extensive cell death [192]. This evidence concerns the gene FASN and neoplasm.